Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN)
暂无分享,去创建一个
K. Matthews | K. Sutton-Tyrrell | R. Wildman | S. Hollenberg | L. Powell | Karen A Matthews | Susan A Everson-Rose | J. Johnston | Rachel P Wildman | Kim Sutton-Tyrrell | Lynda H Powell | Alicia B Colvin | Steven Hollenberg | Janet M Johnston | Susan A. Everson‐Rose | A. Colvin | S. Everson‐Rose | K. Matthews
[1] J. Manson,et al. Estrogen therapy and coronary-artery calcification. , 2007, The New England journal of medicine.
[2] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[3] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[4] R A Kronmal,et al. Compensatory increase in common carotid artery diameter. Relation to blood pressure and artery intima-media thickness in older adults. Cardiovascular Health Study. , 1996, Stroke.
[5] S Hulley,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[6] S Glagov,et al. Shear stress regulation of artery lumen diameter in experimental atherogenesis. , 1987, Journal of vascular surgery.
[7] J. Manson,et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. , 2007, JAMA.
[8] M. Szklo,et al. Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. , 2002, American journal of epidemiology.
[9] P. Touboul,et al. Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. , 1996, Stroke.
[10] C. Lyttle,et al. The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor-κB in HepG2 Cells. , 2000, Endocrinology.
[11] W. Kannel,et al. Menopause and risk of cardiovascular disease: the Framingham study. , 1977, Annals of internal medicine.
[12] Diederick E Grobbee,et al. Common Carotid Intima-Media Thickness and Risk of Acute Myocardial Infarction: The Role of Lumen Diameter , 2005, Stroke.
[13] E. Barrett-Connor,et al. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women , 1995, BMJ.
[14] A. Quyyumi,et al. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.
[15] C. Otto. Cardiovascular Health and Disease in Women , 1994 .
[16] Donald Lloyd-Jones,et al. Sex Hormone–Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nation (SWAN) , 2005, Circulation.
[17] R. Karas,et al. Is the WHI relevant to HRT started in the perimenopause? , 2004, Endocrine.
[18] A. Whittemore,et al. Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.
[19] Endogenous androgens and carotid intimal-medial thickness in women. , 1999, The Journal of clinical endocrinology and metabolism.
[20] D. K. Rorie,et al. Effects of estradiol on release and disposition of norepinephrine from nerve endings. , 1980, The American journal of physiology.
[21] R. Karas,et al. Molecular and Cellular Basis of Cardiovascular Gender Differences , 2005, Science.
[22] G. Garcı́a-Cardeña,et al. 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. , 1997, Circulation research.
[23] J. Price,et al. Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study , 1997, Steroids.
[24] Lewis H Kuller,et al. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. , 2004, Journal of the American College of Cardiology.
[25] David Handelsman,et al. Androgens and cardiovascular disease. , 2003, Endocrine reviews.
[26] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[27] S. Crawford,et al. Design, survey sampling and recruitment methods of SWAN: A multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition , 2000 .
[28] M. Chappell,et al. Estrogen regulation of angiotensin-converting enzyme mRNA. , 1999, Hypertension.
[29] M. Jensen-Urstad,et al. Carotid artery diameter correlates with risk factors for cardiovascular disease in a population of 55-year-old subjects. , 1999, Stroke.
[30] W Riley,et al. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. , 1996, Stroke.
[31] J. Puolakka,et al. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. , 1995, The Journal of clinical endocrinology and metabolism.
[32] C. Lyttle,et al. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. , 2000, Endocrinology.